BOSTON, March 9, 2017 /PRNewswire/ -- Fight Colorectal Cancer (Fight CRC) and Cure Forward are pleased to announce a
Colorectal cancer remains the third most commonly diagnosed cancer and the second most common cause of cancer deaths among men and women combined in the United States. It is estimated that this year there will be over 135,000 diagnosed cases and more than 50,000 deaths.
Today there are several treatment options for colorectal cancer patients, some of which are still in the testing phase in clinical trials. Since 2004, targeted therapies alone or in combination with standard chemotherapies have provided more treatment options and better results for patients. Treatments found in clinical trials may offer some patients the best, most advanced treatment options for their diagnosis, but they currently lack the tools to access them. Fight CRC is working on multiple levels to bring information about clinical trials to patients, one of which involves this meaningful partnership with Cure Forward.
Patients who access Cure Forward's website through Fight CRC will be able to connect with a Clinical Trial Navigator from Cure Forward for one-on-one assistance. Cure Forward's Clinical Trial Navigators work with patients and their physicians to build robust clinical and personal profiles to identify advanced treatment options found in clinical trials. Patients visiting Cure Forward for assistance with finding a clinical trial or just looking for resources on colorectal cancer will also have access to Fight CRC resources, information, content and assistance through FightCRC.org and the Fight CRC iCancerHealth app.
"Patients are learning about the latest innovations in cancer treatments from their doctors and the media but they often don't know where to begin," said Anjee Davis, Fight CRC president. "Both Fight CRC and Cure Forward understand how difficult it is for patients and caregivers to navigate the confusing maze of information related to advanced treatments and clinical trials. Our partnership helps patients and their families take the first step in finding a clinical trial. By partnering with Cure Forward, we are able to provide direct access to important resources to help patients with their treatment options. Together we are able to guide them through every step."
"Our goal at Cure Forward is to empower patients to uncover their best outcome," said Frank Ingari, CEO, Cure Forward. "It is through the power of community that patients can find the resources they need during this difficult time. By partnering with Fight CRC, we can help patients navigate this overwhelming landscape and uncover options they may never have found otherwise."
About Fight Colorectal Cancer Fight Colorectal Cancer is a community of activists who find it unacceptable that colorectal cancer – a preventable disease – is the second-leading cause of cancer deaths in the U.S. In 2005, we were founded by survivors and family members who believed in making a difference. Since then we have grown to be a leading, national nonprofit base known for our advocacy. Our team plays an important role in making medical information practical for survivors and their families and provides trusted resources that guide patients from diagnosis through survivorship. We unite the colorectal cancer community by empowering anyone impacted by this disease to share their story, advocate for better policies and get involved in the research process. We are one million strong and we won't stop fighting until there's a cure. Join us at FightCRC.org.
About Cure Forward Cure Forward is revolutionizing how patients access the latest treatments by connecting cancer patients to clinical trials like never before. Through its online platform, Cure Forward works with cancer patients and their care teams to build robust patient profiles that detail a patient's full medical and personal history, including the unique genetic makeup of their cancer. Using this information, Cure Forward matches patients with relevant and active clinical trial options, opening the door to advanced treatments and accelerating medical innovation. Learn more at Cureforward.com.
Media Contact: Sarah Maguire firstname.lastname@example.org 646.849.1430
To view the original version on PR Newswire, visit:http://www.prnewswire.com/news-releases/fight-colorectal-cancer-partners-with-cure-forward-to-improve-patient-access-to-leading-edge-cancer-treatments-300420777.html
SOURCE Cure Forward
Subscribe to our Free Newsletters!
Blood groups are of four important groups determined by the presence or absence of specific ...
Spermatocele is a condition in which there is a blockage in the epididymal duct, resulting in semen ...
Be a blood donor and save lives for your donated blood is separated into blood products or just ...View All